SPRING VALLEY, N.Y., Nov. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. Chief Executive Officer Scott Tarriff will participate in a panel discussion with senior executives from leading U.S. generic companies to discuss the current state of the industry. The executive roundtable will be held at the CIBC World Markets 16th Annual Healthcare Conference on Wednesday, November 9, at 2:00 p.m. EST at the Waldorf-Astoria Hotel in New York City.
The live webcast will be accessible through the CIBC World Markets website at http://www.veracast.com/webcasts/cibcwm/hc05/52311106.cfm or through the Par Pharmaceutical website at http://www.parpharm.com. A replay will be available at the same link address for one week after the conference, beginning approximately three hours after the presentation.
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic pharmaceuticals through its principal subsidiary, Par Pharmaceutical, Inc. The company is also developing an additional line of branded pharmaceutical products, the first of which is Megace(R) ES, for specialty markets. Par currently manufactures, markets or licenses more than 90 prescription drugs. For press release and other company information, please visit http://www.parpharm.com.
Audio: http://www.veracast.com/webcasts/cibcwm/hc05/52311106.cfmPar Pharmaceutical Companies, Inc.
CONTACT: Stephen J. Mock, or Cecelia C. Heer, both of Par PharmaceuticalCompanies, Inc., +1-201-802-4000
Web site: http://www.parpharm.com/
